glp-1 drugs and muscle loss Hidden Risks of Inhibitors: "Ozempic Face" GLP-1 Drugs & What They

Although minocycline showed anti-inflammatory and neuroprotective effects preclinically and crosses the bloodbrain barrier [195, 196], randomized clinical trials in HAND did not improve cognitive benefit [197]

Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis and macrophage-derived tissue factor activity in rats

Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity

The Pipeline Is Moving Beyond First-Generation GLP-1 Drugs: New approaches, including amylin analogues, triple agonists and oral therapies, are reshaping the next wave of development

Protective effects of sulforaphane preventing inflammation and oxidative stress to enhance metabolic health: A narrative review